637 related articles for article (PubMed ID: 19660368)
1. A comparison before and after aprotinin was suspended in cardiac surgery: different results in the real world from a single cardiac center in China.
Wang X; Zheng Z; Ao H; Zhang S; Wang Y; Zhang H; Li L; Hu S
J Thorac Cardiovasc Surg; 2009 Oct; 138(4):897-903. PubMed ID: 19660368
[TBL] [Abstract][Full Text] [Related]
2. Aprotinin in cardiac surgery patients: is the risk worth the benefit?
Stamou SC; Reames MK; Skipper E; Stiegel RM; Nussbaum M; Geller R; Robicsek F; Lobdell KW
Eur J Cardiothorac Surg; 2009 Nov; 36(5):869-75. PubMed ID: 19782574
[TBL] [Abstract][Full Text] [Related]
3. Aprotinin in primary cardiac surgery: operative outcome of propensity score-matched study.
Ngaage DL; Cale AR; Cowen ME; Griffin S; Guvendik L
Ann Thorac Surg; 2008 Oct; 86(4):1195-202. PubMed ID: 18805159
[TBL] [Abstract][Full Text] [Related]
4. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
5. Effects of aprotinin on short-term and long-term outcomes after coronary artery bypass grafting surgery.
Wang X; Zheng Z; Ao H; Zhang S; Wang Y; Zhang H; Hu S
Ann Thorac Surg; 2010 May; 89(5):1489-95. PubMed ID: 20417766
[TBL] [Abstract][Full Text] [Related]
6. Bleeding in cardiac surgery: the use of aprotinin does not affect survival.
Pagano D; Howell NJ; Freemantle N; Cunningham D; Bonser RS; Graham TR; Mascaro J; Rooney SJ; Wilson IC; Cramb R; Keogh BE
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):495-502. PubMed ID: 18329459
[TBL] [Abstract][Full Text] [Related]
7. The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery.
Karkouti K; Wijeysundera DN; Yau TM; McCluskey SA; Tait G; Beattie WS
Anesth Analg; 2010 Jan; 110(1):21-9. PubMed ID: 19910626
[TBL] [Abstract][Full Text] [Related]
8. Use of aprotinin in cardiac surgery: effectiveness and safety in a population-based study.
Jakobsen CJ; Søndergaard F; Hjortdal VE; Johnsen SP
Eur J Cardiothorac Surg; 2009 Nov; 36(5):863-8. PubMed ID: 19782573
[TBL] [Abstract][Full Text] [Related]
9. Retrospective cohort analysis of a single dose of aprotinin use in children undergoing cardiac surgery: a single-center experience.
Fan Y; Lin R; Yang L; Ye L; Yu J; Shu Q
Paediatr Anaesth; 2013 Mar; 23(3):242-9. PubMed ID: 23189963
[TBL] [Abstract][Full Text] [Related]
10. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
Maslow AD; Chaudrey A; Bert A; Schwartz C; Singh A
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):6-15. PubMed ID: 18249324
[TBL] [Abstract][Full Text] [Related]
11. Aprotinin use in cardiac surgery patients at low risk for requiring blood transfusion.
Kristeller JL; Stahl RF; Roslund BP; Roke-Thomas M
Pharmacotherapy; 2007 Jul; 27(7):988-94. PubMed ID: 17594204
[TBL] [Abstract][Full Text] [Related]
12. A randomized, controlled trial of aprotinin in neonates undergoing open-heart surgery.
Williams GD; Ramamoorthy C; Pentcheva K; Boltz MG; Kamra K; Reddy VM
Paediatr Anaesth; 2008 Sep; 18(9):812-9. PubMed ID: 18768040
[TBL] [Abstract][Full Text] [Related]
13. Aprotinin may decrease blood loss in complex adult spinal deformity surgery, but it may also increase the risk of acute renal failure.
Okubadejo GO; Bridwell KH; Lenke LG; Buchowski JM; Fang DD; Baldus CR; Nielsen CH; Lee CC
Spine (Phila Pa 1976); 2007 Sep; 32(20):2265-71. PubMed ID: 17873821
[TBL] [Abstract][Full Text] [Related]
14. Aprotinin is safe in pediatric patients undergoing cardiac surgery.
Backer CL; Kelle AM; Stewart RD; Suresh SC; Ali FN; Cohn RA; Seshadri R; Mavroudis C
J Thorac Cardiovasc Surg; 2007 Dec; 134(6):1421-6; discussion 1426-8. PubMed ID: 18023656
[TBL] [Abstract][Full Text] [Related]
15. The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery.
Breuer T; Martin K; Wilhelm M; Wiesner G; Schreiber C; Hess J; Lange R; Tassani P
Eur J Cardiothorac Surg; 2009 Jan; 35(1):167-71; author reply 171. PubMed ID: 19027313
[TBL] [Abstract][Full Text] [Related]
16. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
[TBL] [Abstract][Full Text] [Related]
17. The impact of aprotinin on postoperative renal dysfunction in neonates undergoing cardiopulmonary bypass: a retrospective analysis.
Guzzetta NA; Evans FM; Rosenberg ES; Fazlollah TM; Baker MJ; Wilson EC; Kaiser AM; Tosone SR; Miller BE
Anesth Analg; 2009 Feb; 108(2):448-55. PubMed ID: 19151271
[TBL] [Abstract][Full Text] [Related]
18. Aprotinin and renal dysfunction after pediatric cardiac surgery.
Székely A; Sápi E; Breuer T; Kertai MD; Bodor G; Vargha P; Szatmári A
Paediatr Anaesth; 2008 Feb; 18(2):151-9. PubMed ID: 18184247
[TBL] [Abstract][Full Text] [Related]
19. [Aprotinin (Antilysin Spofa)--its effect on decreasing hemorrhage in the postoperative period in hip arthroplasty].
Cvachovec K; Sechovská H; Berousek J; Popelka S; Hladíková M
Acta Chir Orthop Traumatol Cech; 2001; 68(5):311-4. PubMed ID: 11759474
[TBL] [Abstract][Full Text] [Related]
20. Does the combination of aprotinin and angiotensin-converting enzyme inhibitor cause renal failure after cardiac surgery?
Kincaid EH; Ashburn DA; Hoyle JR; Reichert MG; Hammon JW; Kon ND
Ann Thorac Surg; 2005 Oct; 80(4):1388-93; discussion 1393. PubMed ID: 16181876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]